A deeper understanding of the pathways involved in the progression of these cancers helps to advance the development of prevention and treatment strategies. The collaboration between basic and clinical researchers allows us to identify the issues to resolve in the way we treat patients with urological diseases in a more simple way. This allows strategic elements to be applied that, starting with specific clinical aspects, study the basic molecular mechanisms of the progression of the pathology.

The group has multiple lines of research focused mainly on the development of new strategies and the creation of new tools to help in the diagnosis, prognosis and treatment of urological diseases. Also in the identification of mechanisms and weaknesses operating in the dissemination of prostate cancer, and the study of new treatments for prostate diseases, urological tumours and experimental laparoscopic surgery. 

Visit the research group’s page


Subscribe to our newsletters and be a part of Vall d'Hebron Campus

Select the newsletter you want to receive:

By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights".
Operated by: Vall d’Hebron University Hospital Foundation – Research Institute.
Purpose: Manage the user’s contact information.
Legitimisation: Express acceptance of the privacy policy.
Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use.
Source: The interested party themselves.